On May 21, the Chinese pharmaceutical white horse stock “Changchun High-Tech” took a dive in the afternoon, with its share price falling to a halt and its market value evaporating by RMB 21 billion.
The Daily Economic News reported that as of press time, the stock plunged 9.9% to 455.5 yuan (RMB, same below), with turnover rapidly expanding to 7.57 billion yuan, a recent high, and the latest market value of 184.8 billion yuan, evaporating 21 billion yuan. It is worth mentioning that growth hormone giant Anke Bio also dived and plunged in the afternoon, with the stock plunging 13.48% as of press time.
In response to the sudden flash crash, the stock bar fever soared sharply, with some netizens leaving messages: “A day loss of more than 40,000, medicine to buy two are down, in the jackpot!”
As of March 31 this year, the number of shareholders of Changchun High-tech is 66,600 households. It is estimated that this part of the investors have been sitting on pins and needles.
On May 20, Changchun High-tech surprised 1.938 billion yuan of huge block trades. Who is selling “Northeast Maotai”? The market has caused speculation.
According to “Securities Times” e company reports, according to the transaction details, Changchun High-tech this 1.938 billion yuan of large transactions, a total of 34, the number of transactions 4,124,200 shares, accounting for 1.01% of the total share capital of the company. The transaction price was 470.01 yuan per share, a discount of about 7% from the closing price of 506.11 yuan per share on the same day.
It is noteworthy that the 34 transactions, the seller’s business office are Zhongtian Guofu Securities Co., Ltd Jilin Branch, the buyer except for a transaction of 31,102.07 million yuan for Hangzhou Jiefang East Road Securities Business Department, the other 32 are institutions.
From the viewpoint of the holdings at the end of the first quarter of 2021, shareholders holding more than 4,124,200 shares can be at least the eighth largest shareholder of the company and the sixth largest in the list of circulating shareholders.
As of the end of the first quarter, the top 5 circulating shareholders of Changchun High-Tech, respectively, are Changchun High-Tech Chaoda Investment Limited, Hong Kong Securities Clearing Company Limited, Central Huijin Asset Management Company Limited, China-Europe Medical Health Mixed Securities Investment Fund, and National Social Security Fund One Hundred and Eight Portfolio.
However, on April 20 this year, Changchun High-tech ushered in a ban, the number of shares unblocked up to 19,966,900. Among them, natural shareholders Jin Lei 15,555,700 shares and Lin Dianhai 4,414,000 shares. The number of shares in the bulk transaction of Changchun High-tech has reached 1% of the total share capital. Restricted shares have just been released Jin Lei or Lin Dianhai, it is possible that the seller of this bulk transaction.
Recent Comments